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Abstract
Background: Genome-wide association studies have identified hundreds of loci that influence a wide variety of complex
human traits; however, little is known regarding the biological mechanism of action of these loci. The recent accumulation
of functional genomics (“omics”), including metabolomics data, has created new opportunities for studying the functional
role of specific changes in the genome. Functional genomic data are characterized by their high dimensionality, the
presence of (strong) statistical dependency between traits, and, potentially, complex genetic control. Therefore, the analysis
of such data requires specific statistical genetics methods. Results: To facilitate our understanding of the genetic control of
Received: 12 December 2017; Revised: 3 May 2018; Accepted: 6 November 2018
C© The Author(s) 2018. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium,
provided the original work is properly cited.
1
D
ow
nloaded from
 https://academ
ic.oup.com
/gigascience/article-abstract/7/12/giy137/5214749 by guest on 21 N
ovem
ber 2019
2 A network-based genetic analisys of human metabolome
omics phenotypes, we propose a trait-centered, network-based conditional genetic association (cGAS) approach for
identifying the direct effects of genetic variants on omics-based traits. For each trait of interest, we selected from a
biological network a set of other traits to be used as covariates in the cGAS. The network can be reconstructed either from
biological pathway databases (a mechanistic approach) or directly from the data, using a Gaussian graphical model applied
to the metabolome (a data-driven approach). We derived mathematical expressions that allow comparison of the power of
univariate analyses with conditional genetic association analyses. We then tested our approach using data from a
population-based Cooperative Health Research in the region of Augsburg (KORA) study (n = 1,784 subjects, 1.7 million
single-nucleotide polymorphisms) with measured data for 151 metabolites. Conclusions: We found that compared to
single-trait analysis, performing a genetic association analysis that includes biologically relevant covariates can either gain
or lose power, depending on specific pleiotropic scenarios, for which we provide empirical examples. In the context of
analyzed metabolomics data, the mechanistic network approach had more power compared to the data-driven approach.
Nevertheless, we believe that our analysis shows that neither a prior-knowledge-only approach nor a phenotypic-data-only
approach is optimal, and we discuss possibilities for improvement.
Keywords: genome-wide association study; multivariate model; metabolomics; conditional analysis; pleiotropy
Background
Genome-wide association studies (GWASs) are a highly popu-
lar method for identifying alleles that affect complex traits in
humans, including the risk of common diseases. In the past
decade, GWASs have enabled the identification of thousands of
loci, significantly increasing our understanding of the genetic
basis underlying the control of complex human traits [1]. On the
other hand, this has had only a limited impact on the develop-
ment of biomarkers and therapeutic agents; in most cases, any
association found using a GWAS approach can only serve as a
starting point for future research, rather than providing a direct
answer to the question of the genetic region’s precise biologi-
cal function. The recent accumulation of functional genomics
(or “omics” for short) data, including information regarding the
levels of gene expression (the transcriptome), metabolites (the
metabolome), proteins (the proteome), and glycosylation (the
glycome), can provide new insight into the functional role of spe-
cific changes in the genome [2, 3].
Metabolomics is an emerging field that has been studied ex-
tensively in the past decade. A number of GWASs of metabo-
lites have been performed using various platforms [4–8], reveal-
ing literally dozens of loci associated with variations in vari-
ous lipid species, amino acids, and other small molecules. Link-
ing the variants that underlie these variations in metabolomics
with various diseases can provide functional insight into the
many disease-related associations that were reported in previ-
ous studies, including cardiovascular and kidney disease, type
2 diabetes, cancer, gout, venous thromboembolism, and Crohn’s
disease [5].
However, analyzing metabolomics data requires specialized
statistical methods due to their characteristically high dimen-
sionality and the presence of statistical dependencies that re-
flect biological relationships between different variables. Con-
ventional univariate GWAS (uGAS) approaches ignore any possi-
ble dependencies between different omics traits, which can con-
found the biological interpretation of the results andmay lead to
a loss of statistical power. On the other hand, utilizingmultivari-
ate phenotype information increases the statistical power of the
association tests compared to univariate analysis [9–12]. Despite
a large number of methodological studies, only a few empiri-
cal multivariate GWASs have been published using data for hu-
mans. We recently demonstrated [13] that using a multivariate
analysis can substantially increase the power of locus identifica-
tion in the context of human N-glycomics. Indeed, not only did
our multivariate analysis double the number of loci identified
in the analysis sample but also all five novel loci were strongly
replicated. With respect to metabolomics, Inouye et al. [6] per-
formed a multivariate GWAS on 130 metabolites (grouped in 11
sets) measured in approximately 6,600 individuals. They found
thatmultivariate analysis doubled the number of loci detected in
this sample; seven of these additional loci discoveredwere novel
loci that had not been identified previously in other GWAS anal-
yses of related traits. While no replication of novel loci was per-
formed by Inouye et al., we compared the authors’ results with
a recently published univariate GWAS of metabolomics derived
from a cohort containing nearly 25,000 individuals [8]. We found
that three of the seven single-nucleotide polymorphisms (SNPs)
reported by Inouye et al. have a P-value < 5 × 10−11 for at least
one metabolite (i.e., are significant at the genome-wide level af-
ter Bonferroni correction for 130 analyses). These findings pro-
vide empirical evidence supporting the value of usingmultivari-
atemethods to analyze the genomics ofmetabolic traits, at least
in the context of locus discovery.
It should be noted that these multivariate methods and tests
were developed by statistical geneticists to specifically increase
the power of gene identification. In such “gene-centric” tests, the
model that includes the effects of genotype on multiple traits is
contrasted with the null model in which the gene has no effect
on any trait analyzed. Although useful and powerful for genetic
mapping, this approach may have limited interpretability in a
context in which one is interested in the genetic control and bi-
ology of a specific trait or a subset of traits (the “trait-centered”
view). Several statistical methods have been suggested to ad-
dress the question of which specific traits are affected in an ana-
lyzed ensemble (see, e.g., [10, 14]). One such method is based on
conditional analysis [15], inwhich a “target trait” is analyzed as a
genotype-dependent variable and related traits are included in
the regression model as covariates. Such a modeling approach
allows, at least in theory, one to rule out indirect genetic effects
(e.g., effects that are in fact solely mediated through some other
trait) and study only the genetic effects that directly affect the
trait of interest.
Here, we present a statistical model in which a given trait
depends on a genetic polymorphism and in which a number
of related traits are included in the model as covariates. In this
model, the relationship between the genotype and the trait of in-
terest is our primary focus. Analyzing such a model allows us to
identify the direct effect of genetics on the trait of interest.Math-
ematically, the model is equivalent to the model used by Deng
and Pan [15]. We first compare this conditional genetic associa-
tion (cGAS) approachwith the standardmodel in which a trait of
D
ow
nloaded from
 https://academ
ic.oup.com
/gigascience/article-abstract/7/12/giy137/5214749 by guest on 21 N
ovem
ber 2019
Tsepilov et al. 3
interest depends solely on genotype, without other traits used
as covariates (i.e., the univariate genetic association, or uGAS,
model). We do so by mathematically deriving expressions that
allow us to examine the relative power of the uGAS and cGAS ap-
proaches, and we identify the situations in which these models
are expected to yield different results.
As might be expected, and as demonstrated here, the choice
of covariates plays a critical role in conditional analyses. First,
we use the assumption that the covariates (i.e., biologically rel-
evant traits) are known. Second, we explore the problem of se-
lecting appropriate covariates, and we test the approaches by
performing a proof-of-principle study using metabolomics data
consisting of 151metabolites (Biocrates assay) obtained from the
KORA (Cooperative Health Research in the region of Augsburg)
F4 study (n = 1,785 individuals). Specifically, we select covari-
ates based on existing knowledge from metabolite biochemical
networks (BN-cGAS) and use a data-driven approach based on
Gaussian graphical modeling (GGM-cGAS). Finally, we compare
and discuss the obtained results, and we discuss possible appli-
cations for this analysis based on biologically and/or statistically
relevant traits.
Results
The power of performing a conditional analysis of
genetic associations
We start with the theoretical substantiation and identification
of specific scenarios in which adjusting for biologically relevant
covariates can modify the power of an association analysis.
Let us consider a trait of interest y, covariate c, and genotype
g. We can formulate this problem in terms of a linear regres-
sion as follows: y = μ + βg ∗ g+ βc ∗ c + e, where βg and βc are the
effects of the genotype and covariate, respectively, and e is the
residual noise. Without a loss of generality, we assume that all
random variables in this equation are distributed with a mean
of zero and a standard deviation of 1, making (partial) regres-
sion coefficients equal to (partial) correlation coefficients. Given
these assumptions, the joint distribution of y, g, and c can be
specified using a set of three correlation coefficients, ρyg (the cor-
relation between the trait and the genotype), ρcg (the correlation
between the covariate and the genotype), and ρyc (the correla-
tion between the trait and the covariate). To test the association
between y and g, we use the Wald test, which is defined as the
square of the ratio between the effect estimate and its standard
error, with the latter estimated under the alternative hypothesis
(see [16]). The value of the “univariate” Wald test statistic is cal-
culated as T2u =
n ρˆ2yg
σˆ 2u
, where n is the sample size and σˆ 2u = 1 − ρˆ2yg
is the estimated residual variance of y. For the conditional test,
the Wald test is T2c =
n βˆ2g
σˆ 2c
, where βˆg is the estimated partial cor-
relation between the trait y and the genotype g (estimated from
the conditional model) and σˆ 2c is the estimated residual variance
of y. Note that under the null hypothesis, when n is large, both
T2u and T
2
c are well approximated by chi-square distribution with
one degree of freedom. For genetic association studies, n is thou-
sands or orders of magnitude more.
For the conditional model, βˆg = ρˆyg − βˆc ρˆcg; thus, we can
rewrite T2c = n(ρˆyg − βˆc ρˆcg)2/σˆ 2c . Consequently, the log-ratio of the
conditional and univariate test statistics can be partitioned into
two components:
log
(
T2c
T2u
)
= log
(
σˆ 2u
σˆ 2c
)
+ log
⎛
⎝[1 − βˆc ρˆcg
ρˆyg
]2⎞⎠ (1)
Because the first term in Equation (1) is dependent only upon
residual variances of the two models, we call this term the
“noise” component. The second term depends upon the corre-
lations between traits and between the traits and the genotype;
we call this term the “pleiotropic” component. Because the noise
component (σˆ 2u /σˆ
2
c ) is always ≥1, any possible decrease in the ra-
tio between univariate and conditional tests is determined by
the sign and the magnitude of the term βˆc ρˆcg/ρˆyg. If this term is
negative, there will always be an increase in the power of the
conditional analysis.
We can re-write βˆc ρˆcg/ρˆyg as βˆc ρˆ∗yc , where ρˆ
∗
yc = ρˆcg/ρˆyg is the
component of the correlation between trait y and covariate c,
which is induced by the variation in the genotype g. This quan-
tity takes a central place in aMendelian randomization analysis,
which uses a genetic variation to anchor the causality arrow and
consequently infers a causal relation between various traits (see,
e.g., [17]). Note that whereas ρˆ∗yc reflects the covariance between
the trait and the covariate induced by the effect of the genotype,
βˆc is conditional on the genotype and is related to the residual
sources of covariance between y and c.
In general, the genetically induced covariance and the resid-
ual covariance are expected to have a concordant sign (see Dis-
cussion for details and relevant references). Thus, we conclude
somewhat surprisingly that when genotype-induced and envi-
ronmental correlations are similar in sign (i.e., both are posi-
tive or both are negative), the product βˆc ρˆ∗yc is positive and the
contribution of the second term in Equation (1) to the relative
power is negative. Note that the contribution of the first term
in Equation (1) is always positive; therefore, even if βˆc ρˆ∗yc is posi-
tive, the power of a conditional analysis may still be higher than
the power of a univariate analysis. In contrast, an “unexpected”
product (in which the signs are different and hence βˆc ρˆ∗yc is neg-
ative) contributes positively to the relative power of the condi-
tional model. Note that in such a situation, the power of a con-
ditional analysis will always be higher than the power of a uni-
variate analysis.
We can readily extend Equation (1) to a situation in which k
covariates are included in the conditional model. Denoting the
estimated coefficients of correlation between g and covariate i as
ρˆgi and the estimated partial correlation between y and covariate
i as βˆi yields the following equation:
log
(
T2c
T2u
)
= log
(
σˆ 2u
σˆ 2c
)
+ log
⎛
⎝[1 − 1
ρˆyg
k∑
i=1
βˆi ρˆgi
]2⎞⎠ (2)
When appropriate covariates are selected, performing cGAS
using individual-level data becomes rather trivial and can be
achieved using standard statistical and software tools in which
one estimates the effects of a SNP and covariates. However, cGAS
becomes somewhat less trivial if one chooses to use summary-
level univariate GWAS data such as data available from pre-
viously published studies. The formalization of cGAS in terms
of summary univariate GWAS statistics is described in Supple-
mentary Note 1. Here, we used methods based on analyzing
summary-level data.
Network-based selection of covariates
The ability to select appropriate covariates is extremely impor-
tant, as it can have direct implications regarding the outcome
of the analysis. If the biological/biochemical relationships be-
tween traits of interest are known and are summarized in a
database(s), this knowledge can be used directly, e.g., by using
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all direct neighbors as covariates. We refer to this approach as a
biochemical network-driven cGAS (BN-cGAS). Alternatively, the
network can be reconstructed in a hypothesis-free, empirical
manner from the data, e.g., using a GGM [18]. We refer to this
approach as a GGM-cGAS.
We compared cGAS and uGAS by performing a genome-wide
analysis of genetic effects using summary-level data obtained
from the KORA F4 study. This study included 151 metabolites
measured in 1,784 individuals using the Biocrates assay and im-
puted at 1,717,498 SNPs.
First, we examined the potential of using cGAS when the co-
variates are selected based on a known biochemical network
(i.e., BN-cGAS). Thus, our analysis was restricted to a subset
of 105 metabolites for which at least the one-reaction-step im-
mediate biochemical neighbors are known [18]. This biochemi-
cal network incorporates only lipid metabolites, and the path-
way reactions cover two groups of pathways: fatty acid biosyn-
thesis reactions, which apply to the metabolite classes lyso-PC,
diacyl-PC, acyl-alkyl-PC, and sphingomyelins, and β-oxidation
reactions that reflect fatty acid degradation and apply to acyl-
carnitines. The β-oxidation model consists of a linear chain of
C2 degradation steps (C10 to C8 to C6, etc.). The number of co-
variates ranged from 1 to 4, with mean and median values of
2.48 covariates and 2 covariates, respectively.
Table 1 lists the 11 loci that were significant in either BN-
cGAS or uGAS and fell into known associated regions (see Sup-
plementary Note 2). Of these 11 loci, 10 and 9 loci could be iden-
tified by BN-cGAS and uGAS, respectively. Compared to uGAS,
BN-cGAS identified one fewer locus (ETFDH) but identified two
more (ACSL1 for PC ae C42:5 and PKD2L1 for lyso-PC a C16:1). It
is interesting to note that for ACSL1, the effect of SNP rs4862429
on PC ae C42:5 was highly significant (P = 7e-11) with BN-cGAS
but was not significant (P = 0.7) with uGAS; this outcome is to be
expected under the model of unexpected pleiotropy.
Next, to test whether using BN-cGAS increases the average
power of the association analysis, we compared the BN-cGAS
and uGAS chi-square test results for the loci listed in Table 1.
Within a given locus,we compared themaximum test value. The
average ratio of the maximum test statistic between BN-cGAS
and uGAS was 1.47, indicating that, on average, BN-cGAS led to
higher test statistic values. However, when we used a paired-
sample Wilcoxon test to compare the best chi-square test re-
sults between BN-cGAS and uGAS, the difference between the
two methods was not significant (P = 0.123) (see Supplementary
Table S1A).
For the SNPs listed in Table 1, we then used Equation (2) to
partition the log-ratio of the BN-cGAS and uGAS statistics val-
ues into “noise” and “pleiotropic” components. As shown in Fig.
1, the regression slope of the second (i.e., “pleiotropic”) compo-
nent is considerably higher than the slope of the noise compo-
nent; in other words, the ratio is determined primarily by the
pleiotropic term in Equation (2). Moreover, with the exception
of the SLC22A4 locus, the SNP-trait pairs for which BN-cGAS
had increased power are the pairs in which the second term
in Equation (2) is either positive or close to zero. In contrast, in
the SNP-trait pairs that were not identified using BN-cGAS, the
“pleiotropic” term in Equation (2) had a strong negative contri-
bution.
Next, we investigated the variance-covariance structure of
the loci with positive and negative pleiotropic terms. We there-
fore selected a locus in which the pleiotropic component’s con-
tribution to power was positive (rs174547 at FADS1) and a locus
in which the pleiotropic component’s contribution to power was
negative (rs8396 at ETFDH). Figure 2 shows the corresponding
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Figure 1: Decomposition of the log-T2 ratio for cGAS and uGAS into pleiotropic and noise components. Vertically grouped trios (each composed of a square, triangle,
and asterisk) correspond to 1 of 14 associations in Table 1. The position of a trio on the x-axis corresponds to the log-ratio between conditional and univariate test
statistic. On the y-axis, the asterisk corresponds to the log-ratio of cGAS and uGAS T2 statistics. The value of the pleiotropic component is depicted by a square, and
the value of the noise component is depicted by a triangle. Each trio is shown in gray, except the trios representing the ACADM, SLC22A4, and PLEKHH1 loci, for which
we have two different associations. The three dotted lines correspond to the regression lines for the two components and their sum. The four dark-green vertical
lines indicate the associations that were significant in the cGAS analysis but not in the uGAS analysis, and the two dark-red lines indicate the associations that were
significant only in the uGAS analysis.
Figure 2:Matrix of correlations (above diagonal line) and the partial regression coefficients of the trait of interest on the SNP genotype and covariate(s) (the first column)
for the FADS1 (A) and ETFDH (B) loci. The result of the univariate analysis of regression of the corresponding traits onto SNPs is presented in Supplementary Table S1C.
Names of traits used as covariates are in red. The number in a cell indicates the value of correlation (partial regression coefficient). The area of a square is proportional
to the absolute value of correlation (partial regression coefficient); the effect magnitude is also reflected by a square’s color (the scale provided at the bottom of the
graph). The FADS1 locus represents scenario in which the pleiotropic term in Equation (2) is strongly positive, while for ETFDH this term is negative.
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correlations between the SNP, the trait, and the covariates in-
volved, together with the partial coefficients for the conditional
regression of the trait on the SNP and the covariates. With re-
spect to FADS1 (Fig. 2A), the correlations between the SNP and
the trait (lyso-PC a C20:4) and between the SNP and the covari-
ate (lyso-PC a C20:3) are in opposite directions, generating nega-
tive genetically induced covariance between lyso-PC a C20:4 and
lyso-PC a C20:3. In contrast, the residual correlation between the
trait and the covariate is positive. Therefore, the value of the par-
tial regression coefficient between the SNP and lyso-PC a C20:4,
conditional on lyso-PC a C20:3, is greater than that of the coeffi-
cient of regression without covariates.
With respect to the second example, ETFDH (Fig. 2B), we
found that the conditional regression of C10 on rs8396 and two
covariates (C8 and C12, two medium-chain acylcarnitines) led
to a smaller SNP partial regression coefficient compared to an
unconditional regression; this is because all of the terms in
k∑
i=1
βˆi ρˆgi/ρˆyg are positive.
Although using a known biochemical network to select co-
variates has many advantages, it may be somewhat impractical
and perhaps even harmful, as our biochemical knowledge is still
relatively incomplete. Therefore, we explored the potential of
performing a cGAS in which the covariates are selected using a
data-driven approach (GGM-cGAS). The network of metabolites
was reconstructed using GGMs based on partial correlations. For
a given metabolite, we selected covariates based on significant
partial correlations. Specifically, we used the following threshold
as proposed previously [18]: a P-value ≤ (0.01/number of calcu-
lated partial correlations), which corresponds to a cutoff at p ≤
8.83 × 10−7. The network used in our analysis is shown in Sup-
plementary Fig. S1.
To compare GGM-cGAS with BN-cGAS, we used the same
set of metabolites that we used for BN-cGAS to run our GGM-
cGAS analysis; these results are presented in Supplementary Ta-
ble S1B. We found 15 SNP-trait pairs clustered at 10 known loci
(see Supplementary Note 2) that were detected by either GGM-
cGAS or BN-cGAS. More covariates were included in the GGM-
cGAS analysis (ranging from 1 to 18, with mean and median
values of 7.6 covariates and 7 covariates, respectively) than in
the BN-cGAS analysis. Thus, we predicted that GGM-cGASwould
have relatively more power than BN-cGAS due to reduced noise
(term 1 in Equation [2]); on the other hand, GGM-cGASmight lose
power because of reduced occurrence of unexpected pleiotropy
(term 2 in Equation [2]).
For the best SNP-trait pairs detected by GGM-cGAS or BN-
cGAS, we computed the components in Equation (2) and com-
pared these components using a paired-sample Wilcoxon test.
We found that the noise component in Equation (2) was always
larger for GGM-cGAS, with a mean difference of 0.29 (P = 6 ×
10−5). Moreover, the second “pleiotropic” component in Equa-
tion (2) was generally smaller for GGM-cGAS than for BN-cGAS,
with a mean difference of −0.47 (P = 0.015). Nevertheless, for 3
of 15 GGM-cGAS SNP-trait pairs, the pleiotropic component was
positive. The average chi-square valuewas 25% smaller for GGM-
cGAS than for BN-cGAS, indicating an average loss of power (al-
though this loss was not significant; P = 0.5 based on a paired
Wilcoxon test).
Next, we investigated further the potential of using cGAS un-
der realistic conditions to a full extent by analyzing all 151 avail-
able metabolites using GGM-cGAS and comparing these results
with the results of uGAS (Table 2 and Supplementary Fig. S2).
In total, uGAS detected 15 loci at the genome-wide significance
level p ≤ 5 × 10−8/151 (i.e., P < 3.3 × 10−10). On the other hand,
GGM-cGAS identified 19 significant loci using the same thresh-
old. As expected, the standard errors of the genetic effect esti-
mates were smaller for GGM-cGAS than for uGAS (Table 2 and
Supplementary Fig. S3). A total of 14 loci were detected by both
uGAS and GGM-cGAS. GGM-cGAS failed to identify one locus
that was identified by uGAS (C5:1-DC at rs2943644) but identified
five loci that were missed by uGAS. Three of the five loci identi-
fied solely by GGM-cGAS affect amino acids, and the remaining
two loci affect acylcarnitines. It is important to note that the loci
identified by BN-cGAS (when we analyzed 105 metabolites) are
a subset of the 19 loci that were identified by GGM-cGAS (when
we used all 151 metabolites).
Finally, we searched the available literature for the loci listed
in Table 2 (see Supplementary Note 2 for details). From the 20
loci that we report here, 15 were found to be significant at the
genome-wide level in a recent large (n = 7,478) meta-analysis
of Biocrates metabolomics data reported by Draisma et al. [7].
Some of the metabolites analyzed in our study were not an-
alyzed by Draisma et al. [7]. Nevertheless, for 11 of these 15
loci, we observed a significant association for the same SNP-
metabolite pair; for 3 loci, the strongest association was with
a metabolite in the same class; and for 1 locus, the strongest
association was with a metabolite from a different lipid class
(see Supplementary Table S2). For the other five loci that were
not significant in the study by Draisma et al. [7], we determined
whether these five loci were significant and replicated in a study
by Tsepilov et al. [19]. It should be noted that Tsepilov et al.
analyzed the ratios of metabolites and also used the KORA F4
dataset in their discovery stage, although they used another co-
hort (TwinsUK) for replication. Of these five loci, two were also
significant in the study by Tsepilov et al. [19]. Moreover, for both
of these loci, the metabolite analyzed in our study was included
in the ratios analyzed by Tsepilov et al. One of the five loci
was associated with the same trait in two other studies [20, 21].
Finally, we found no prior published evidence of any associa-
tion with metabolites for rs2943644 (LOC646736) or rs17112944
(LOC728755). Taking into account that this association was not
found in (much) biggermeta-analysis, we conclude the observed
associations with rs17112944 and rs2943644 as likely false posi-
tives, and these two loci were excluded from further considera-
tion.
Discussion
We report a new “trait-centric” approach for analyzing genetic
determinants of multivariate “omics” traits by performing a
network-based cGAS analysis. In the context of metabolomics,
for each trait we selected a set of other metabolites to be used
as covariates in our genetic association analysis. The selec-
tion of covariates can be either mechanistic (e.g., based on
known biological relationships between traits of interest) or data
driven (e.g., based on partial correlations). Importantly, this ap-
proach can use either individual-level or summary-level data.
First, we mathematically compared the power of conditional
and standard single-trait genetic association analyses (uGAS),
and we identified scenarios in which these analyses are ex-
pected to produce different results. Next, we applied cGAS to
151 metabolomics traits (Biocrates panel) in a large (n = 1,784
individuals) population-based KORA cohort.
We found that the log-ratio between the cGAS and uGAS test
statistic can be decomposed in a “noise” component (which de-
pends on residual variance of the trait and is always positive)
and a “pleiotropic” component. The pleiotropic component is
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negative in cases in which genetically induced covariance (be-
tween the trait of interest and the trait used as the covariate)
and the residual covariance have the same sign (i.e., act in the
same direction). The pleiotropic component is positive in cases
inwhich the genetically induced covariance and residual covari-
ance act in opposite directions.
Should one expect that genetically induced covariance and
residual covariance act in the same or opposite directions? In
essence, this is a question about the architecture of pleiotropy: is
a pleiotropic genetic variant expected to induce the same covari-
ance as would be induced by non-genetic mechanisms? It has
been reasoned that in randomly bred populations, the genetic
correlations are expected to arise primarily from pleiotropic
gene action [22]. In such populations, a study and comparison of
genetic and environmental correlations, while unable to provide
single-variant resolution, may provide a general notion of what
may be expected for consistency/anti-consistency between ge-
netic and residual covariance. Based on published literature,
Cheverud [23] and Roff [24] concluded that genetic and environ-
mental correlations normally have both the same sign and the
same magnitude. This pattern is particularly clear for morpho-
logic traits, as opposed to life-history traits (see [25] for review
and additional references). These observations are consistent
with recent studies of genetic correlations between complex hu-
man polygenic traits (see [26]).
Consequently, for complex traits, one may expect that the
sign of the pleiotropic component of the log-ratio between the
cGAS and uGAS tests (individual summands in the second term
of the Equation [2]) is generally negative. It should be noted,
though, that a negative sign for the pleiotropic component does
not necessarily indicate higher power of the uGAS, as the noise
component (the first term in Equation [2]) may still dominate
the log-ratio between the cGAS and uGAS tests. This will hap-
pen, e.g., when ρˆcg (the effect of the genotype on the covariate)
is small while βˆyc (partial residual regression between the trait
and covariate) is relatively large, thereby reducing σˆ 2c .
Nevertheless, in the case of metabolomic traits, genetic and
environmental sources do not necessarily generate consistent
covariance. Moreover, for a given locus that affects the activ-
ity of an enzyme involved in a biochemical reaction, the un-
expected inconsistency between genetically induced covariance
and residual covariance may not be so unexpected after all. In-
deed, consider an allele associated with an increased activity of
an enzyme that converts substrate A into product B. One would
expect that the levels of A and B are positively correlated. One
would also expect that the allele is positively correlated with the
level of product B and negatively correlatedwith the level of sub-
strate A. This is precisely the scenario that yields a positive value
for the second term in Equation (1), thus providing an additional
increase in power above and beyond the power provided by the
first term in Equation (1) (noise reduction).
Our empirical investigation of real data on the genetic asso-
ciation between the genome and metabolites confirmed the ex-
istence of both scenarios. An extreme example of concordance
between genetic covariance and residual covariance is provided
by the effects of rs8396 on C10, with C8 and C12 used as covari-
ates (see Fig. 2B). The ETFDH gene,whichwas prioritized byData-
driven Expression-Prioritized Integration for Complex Traits (DE-
PICT) software (see Materials and Methods section) as the best
candidate in this region (with a false-discovery rate <5%), en-
codes the enzyme electron transfer flavoprotein (ETF) dehydro-
genase, which plays a role in mitochondrial fatty acid oxidation.
During this process, the acyl group is transferred from a long-
chain acylcarnitine to a long-chain acetyl-CoA, which is then ca-
tabolized. ETF dehydrogenase participates in the catabolic pro-
cess by transferring electrons from acyl-CoA dehydrogenase to
the oxidative phosphorylation pathway. Thus, the ETFDH gene
should affect all forms of long-chain acylcarnitines in the same
way, and we can expect that the pleotropic effect of this gene on
the acylcarnitines in our example (C8, C10, C12, etc.) will be uni-
directional. The presence of unidirectional genetic effects and
the positive correlation between these acylcarnitines makes the
second term in Equation (2) negative, which determines that, in
this situation, uGAS has more power than cGAS.
An empirical example of discordance between genetically in-
duced covariance and residual covariance is provided by the ef-
fects of the SNP rs174547 on lyso-PC a C20:4, with lyso-PC a C20:3
used as a covariate. This SNP exhibits opposite correlations with
lyso-PC a C20:4 and lyso-PC a C20:3, resulting in negative ge-
netically induced covariance between these traits. At the same
time, the residual correlation between these traits is positive, re-
sulting in a steep increase in the power of conditional analysis.
In this region, the FADS1/2/3 gene cluster is an attractive can-
didate, providing the detected model with biological relevance.
The FADS1 gene encodes the enzyme fatty acid desaturase 1,
whereas the two traits differ by only one double bond. Thus, this
examplemimics perfectly the biochemical scenario in which we
would expect a conditional analysis to have increased power.
The trait-centric methods considered here provide an attrac-
tive framework to identify and study direct genetic effects on a
trait of interest. Conditional analysis is an attractive option in
cases in which we wish to clearly interpret the results in terms
of the effect of the genotype on a particular trait. Such specific
interpretation may be important when comparing genetic as-
sociation results obtained for our trait of interest with results
obtained for other traits (e.g., using the methods described in
[27–29]). It should be noted, though, that a trait-centric approach
is not intended to maximize the power of identifying genes that
affect metabolomics as a whole. Such a gene-centric viewwould
favor analysis using joint, and not conditional, modeling of sets
of traits. Such an approach can maintain power across a wide
range of scenarios, including the scenario of concordance be-
tween genetically induced and residual covariance [13]. In this
gene-centric framework, other formulations of conditional anal-
ysis have also been proposed [30] in order to specifically in-
crease power of gene identification by selecting covariates that,
using our terminology, affect the “noise reduction” component
of the model while avoiding the problems associated with the
pleiotropic component.
The proper selection of sets of biologically related traits is ex-
tremely important for the conditional genetic association anal-
ysis method described here, as well as for multivariate meth-
ods that model the joint effects of genotype on an ensem-
ble of traits. Here, we considered two alternative approaches—
knowledge based and data driven—to finding the networks of re-
lated traits, with a subnetwork centered around a trait of interest
used as the analyzed set. In principle, in the context of analyzed
metabolomics data, the knowledge-based network approach
has slightly higher power in the context of trait-centric genetic
association analysis. However, we believe that our analysis re-
vealed that both approaches are suboptimal. The knowledge-
based network reconstruction has many advantages, but it may
be somewhat unpractical, as our biochemical knowledge is still
relatively incomplete. Secondly, by reconstructing the network
while relying only on current knowledge, we may be missing
new knowledge that may be revealed by the data. Finally, by in-
cluding neighbors that are based only on biochemical informa-
tion, wemaymiss covariance induced by technical confounders;
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adjusting for thismay increase the power of analysis [30]. Learn-
ing the network from the same data that were used for genetic
analysis has the disadvantages of potentially ignoring existing
knowledge and being sensitive to sample size. Finally, we note
that the total observed correlation between metabolites is de-
termined by the balance between genetic and environmental
sources of covariance. It is possible to imagine a situation in
which total correlation is smaller than one ormore of its compo-
nents, and our analysis provides examples of such a situation.
Wemay speculate that, ideally, one should use amethod that al-
lows one to combine prior knowledge and new information ob-
tained from the data, thereby allowing the simultaneous learn-
ing of the structure of dependencies between different metabo-
lites and between the metabolites and the genome. Such learn-
ing from the data while allowing for the incorporation of previ-
ous knowledge (e.g., biochemical relations between traits) might
be achieved (e.g., by applying a machine-learning approach that
allows for differential shrinkage). It is also important to note that
the proper application of such an approach would require the
availability of vast samples of data, thereby allowing for sepa-
rate training, validation, verification, testing, and replication of
detected dependencies and associations.
Materials and Methods
KORA study
The KORA study (Cooperative Health Research in the region of
Augsburg) is a series of population-based studies in the region of
Augsburg in southern Germany [31]. KORA F4 is a follow-up sur-
vey (conducted from 2006 through 2008) of the baseline KORA S4
survey, which was conducted from 1999 through 2001. All study
protocols were approved by the ethics committee of the Bavar-
ian Medical Chamber, and all participants provided written in-
formed consent.
The concentration of 163metabolitesweremeasured in 3,061
serum samples obtained from KORA F4 participants using flow
injection electrospray ionization tandem mass spectrometry
and the AbsoluteIDQ p150 Kit (Biocrates Life Sciences AG, Inns-
bruck, Austria) [32]. After applying quality-control screening, 151
metabolite measurements were used in our analysis. Details re-
garding the methods and quality control of the metabolite mea-
surements, as well as details regarding the metabolite nomen-
clature, have been published previously [32]. The nomenclature
for the metabolites in this study is provided in Supplementary
Table S3.
Genotyping was performed using the Affymetrix 6.0 SNP ar-
ray (534,174 SNP markers after quality control), with further im-
putation using HapMap2 (release 22) as a reference panel, result-
ing in 1,717,498 SNPs (for details, see ref. [33]). Both the metabo-
lite concentrations and genotype were available for 1,785 partic-
ipants in the KORA F4 study.
Statistical analysis
Partial correlation coefficients and their P-values were calcu-
lated using the “ppcor” package [34] in R. Graphical represen-
tations were generated using the “ggm” [35] package in R. Con-
sistentwith previous studies [18], we considered a partial regres-
sion coefficient to be significant at P < 0.01/(151∗150/2) (i.e., P <
8.83 × 10−7).
For the GWAS analysis, we used OmicABEL software [36].
Prior to GWAS, all traits were first adjusted for the partici-
pant’s sex, age, and batch effect; subsequently, the residual traits
were transformed using an inverse-normal transformation [37].
The genotypes from the KORA F4 cohort were used. Only SNPs
that had a call rate ≥0.95, R2≥0.3, Hardy–Weinberg equilibrium
p≥10−6, and , minor allele frequency (MAF) ≥0.1 (1,717,498 SNPs
in total) were included in the analysis. The genomic control
method was used to correct for any possible inflation of the test
statistics. The genomic control [38] lambda value for all traits
was between 1.00 and 1.03.
In a specific analysis (i.e., cGAS or uGAS), we defined inde-
pendent loci as groups of genome-wide significant associations
that were separated by at least 500 kb or were located on dif-
ferent chromosomes. The strongest association (i.e., the asso-
ciation with the lowest P-value) was selected to represent this
locus. The cGAS and uGAS results were considered to reflect dif-
ferent loci if the strongest associations were in loci that were
separated by at least 500 kb. The threshold for the genome-wide
significance for 151 traits was set to P = 5 × 10−8/151 (i.e., P =
3.31 × 10−10).
When partitioning the log(cGAS/uGAS) test statistics into the
noise and pleiotropic components (see Equation (2) and Fig. 1),
we used all known loci that were significant in either the cGAS
or uGAS analysis (see Table 1). If a locus included two SNPs asso-
ciated with different traits, we included both associations dur-
ing partitioning. If a locus included two SNPs associated with
the same trait, to be conservative, we included only the SNP
with the lower uGAS P-value during partitioning. After parti-
tioning, we determined whether the value of the pleiotropic and
noise components were statistically different using the paired-
samples Wilcoxon test. For comparing the chi-square test re-
sults for the twomethods, for each locus we selected the largest
chi-square value for selected SNP among all analyzed traits. If a
locus had two SNPs,we selected for eachmethod only the largest
chi-square value.
The code for BN-cGAS and GGM-cGAS analyses, and the
code for producing the summary tables and graphs, was imple-
mented in R and is available as a workflow from CodeOcean [39],
a cloud-based computational reproducibility platform.
In silico functional annotation
We conducted functional annotation for our findings. To pri-
oritize genes in associated regions, gene set enrichment, and
tissue/cell-type enrichment analyses, we used DEPICT software
[40] (release 140721) with the following settings: flag loci = 1;
flag genes = 1; flag genesets = 1; flag tissues = 1; param ncores
= 2; and further manual annotation (h37 assembly). All 27 SNPs
(clustered in 20 loci) identified by cGAS or uGAS (see Table 2)
were included in the analysis. If more than one gene was an-
notated for a SNP by DEPICT, we selected the gene with the
lowest nominal DEPICT P-value. In most cases, the results of
manual annotation matched the annotation results using DE-
PICT annotation (see Supplementary Note 2). In addition, we
looked up each SNP using the Phenoscanner [41] database to
check whether it was previously reported to be associated with
metabolic traits at P < 5 × 10−8 and proxy r2 <0.7.
Availability of supporting data
The code produced in relation to this work and all summary
statistics and association data that are necessary to reproduce
our results are stored in the GigaDB database [42] and on the
CodeOcean platform as a reproducible workflow [39]. The in-
formed consent given by the KORA study participants does not
cover the posting of participant-level phenotype or genotype
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data in public databases. However, the KORA data are available
upon request from KORA-gen (https://www.helmholtz-muench
en.de/en/kora/index.html). Requests can be submitted online
and are subject to approval by the KORA board.
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Supplementary Note 1: cGAS using summary level data
Supplementary Note 2: Literature search for loci identified by
cGAS and uGAS
Supplementary Table S1: BN- cGAS and GGM- cGAS for 105
metabolites
Supplementary Table S2: GGM-cGAS and uGAS for 151 metabo-
lites
Supplementary Table S3: List ofmetabolitesmeasured using the
AbsoluteIDQ p150 Kit
Supplementary Figure S1: Partial correlations network
Supplementary Figure S2: Manhattan plots for cGAS and uGAS
for 151 metabolites
Supplementary Figure S3: Comparison of effect estimates and
their standard errors for SNPs from Table 2
Abbreviations
BN: biochemical network; BN-cGAS: cGAS based on biochem-
ical networks; cGAS: conditional GWAS; DEPICT: Data-driven
Expression-Prioritized Integration for Complex Traits; ETF: elec-
tron transfer flavoprotein; GGM-cGAS: Gaussian graphical mod-
eling cGAS based on partial correlations network; GWAS:
genome-wide association study; SNP: single-nucleotide poly-
morphism; uGAS: univariate GWAS (trait-by-trait); KORA study:
Cooperative Health Research in the region of Augsburg; MAF -
minor allele frequency.
Competing interests
Y.S.A. is the founder and co-owner of PolyOmica, a private re-
search organization that specializes in computational and sta-
tistical (gen)omics.
Funding
The KORA study was initiated and financed by the Helmholtz
Center Munich—German Research Center for Environmental
Health, which is funded by the German Federal Ministry of Edu-
cation and Research and by the State of Bavaria. The KORA study
was supported by the Munich Center of Health Sciences (MC-
Health), Ludwig Maximilian University of Munich, as part of the
LMUinnovativ project.
This work was supported by the European Union FP7 frame-
work project Pain-Omics (grant 602736).
S.Z.S. was supported by the Russian Ministry of Science and
Education under the 5–100 Excellence Programme. Y.S.A.was
supported by the Federal Agency of Scientific Organisations via
the Institute of Cytology and Genetics (project 0324-2018-0017).
Y.A.T. was supported by the Federal Agency of Scientific Organi-
sations via the Institute of Cytology and Genetics (project 0324-
2018-0017) and by the Russian Foundation for Basic Research
(project 16-04-00360).
Author contributions
Y.A.T., C.G., and Y.S.A. designed and supervised the study; C.P.,
J.A., K.G., and R.W.-S. collected the data; C.G. andK.S. contributed
data for the analysis; Y.A.T., O.O.Z., and S.Z.S. analyzed the data;
Y.A.T., Y.S.A., C.G., O.O.Z., J.K., and K.S. discussed and interpreted
the results; Y.A.T., O.O.Z., C.G., and Y.S.A. wrote the manuscript.
All authors contributed to and approve the final version of the
manuscript.
Acknowledgments
We thank Athina Spilopoulou and Felix Agakov for helpful
discussions. We also thank Alexander Zlobin and Alexander
Grishenko for help preparing the tables and figures in the
manuscript, and we thank Sophie Molnos for help with data
management. We thank the reviewers Simina Boca and Tim
Ebbels for their very helpful input.
References
1. Visscher PM, Brown MA, McCarthy MI, et al. Five years of
GWAS discovery. Am J Hum Genet 2012;90:7–24.
2. Ritchie MD, Holzinger ER, Li R, et al. Methods of integrating
data to uncover genotype–phenotype interactions. Nat Rev
Genet 2015;16:85–97.
3. van der Sijde MR, Ng A, Fu J. Systems genetics: from GWAS
to disease pathways. Biochim Biophys Acta - Mol Basis Dis
2014;1842:1903–9.
4. Hicks AA, Pramstaller PP, Johansson A, et al. Genetic deter-
minants of circulating sphingolipid concentrations in Euro-
pean populations. PLoS Genet 2009;5:e1000672.
5. Suhre K, Shin S-Y, PetersenA-K, et al. Humanmetabolic indi-
viduality in biomedical and pharmaceutical research. Nature
2011;477:54–60.
6. Inouye M, Ripatti S, Kettunen J, et al. Novel loci for metabolic
networks and multi-tissue expression studies reveal genes
for atherosclerosis. PLoS Genet 2012;8:e1002907.
7. Draisma HHM, Pool R, Kobl M, et al. Genome-wide associa-
tion study identifies novel genetic variants contributing to
variation in blood metabolite levels. Nat Commun England
2015;6:7208.
8. Kettunen J, Demirkan A, Wu¨rtz P, et al. Genome-wide study
for circulatingmetabolites identifies 62 loci and reveals novel
systemic effects of LPA. Nat Commun 2016;7:11122.
9. Cichonska A, Rousu J, Marttinen P, et al. metaCCA: summary
statistics-based multivariate meta-analysis of genome-wide
association studies using canonical correlation analysis.
Bioinformatics 2016;32:1981–9.
10. Stephens M. A unified framework for association analysis
with multiple related phenotypes. PLoS One 2013;8:e65245.
11. O’Reilly PF, Hoggart CJ, Pomyen Y, et al. MultiPhen: joint
model of multiple phenotypes can increase discovery in
GWAS. PLoS One 2012;7:e34861.
12. Galesloot TE, van Steen K, Kiemeney LALM, et al. A compari-
son ofmultivariate genome-wide associationmethods. PLoS
One 2014;9:e95923.
13. Shen X, Klaric´ L, Sharapov S, et al. Multivariate discovery and
replication of five novel loci associated with immunoglobu-
lin G N-glycosylation. Nat Commun 2017;8:447.
14. Schaid DJ, Tong X, Larrabee B, et al. Statistical methods for
testing genetic pleiotropy. Genetics 2016;204:483–97.
15. Deng Y, PanW. Conditional analysis of multiple quantitative
traits based on marginal GWAS summary statistics. Genet
D
ow
nloaded from
 https://academ
ic.oup.com
/gigascience/article-abstract/7/12/giy137/5214749 by guest on 21 N
ovem
ber 2019
Tsepilov et al. 11
Epidemiol 2017;41:427–36.
16. Cox DR, Hinkley DV. Theoretical Statistics. London: Chap-
man Hall; 1974;1:511.
17. Smith GD, Ebrahim S. “Mendelian randomization”: can ge-
netic epidemiology contribute to understanding environ-
mental determinants of disease? Int J Epidemiol 2003;32:1–
22.
18. Krumsiek J, Suhre K, Illig T, et al. Gaussian graphical mod-
eling reconstructs pathway reactions from high-throughput
metabolomics data. BMC Syst Biol. BioMed Central Ltd;
2011;5:21.
19. Tsepilov YA, Shin S-Y, Soranzo N, et al. Nonadditive effects
of genes in humanmetabolomics. Genetics 2015;200:707–18.
20. Xie W, Wood AR, Lyssenko V, et al. Genetic variants associ-
ated with glycine metabolism and their role in insulin sen-
sitivity and type 2 diabetes. Diabetes 2013;62:2141–50.
21. Shin S-Y, Fauman EB, Petersen A-K, et al. An atlas of ge-
netic influences on human blood metabolites. Nat Genet
2014;46:543–50.
22. Falconer DS, Mackay TFC. Introduction to Quantitative Ge-
netics. 4th ed. Pearson; 1996. ISBN:978-0582243026
23. Cheverud JM. A comparison of genetic and phenotypic cor-
relations. Evolution 1988;42:958–68.
24. Roff DA. The estimation of genetic correlations from pheno-
typic correlations: a test of Cheverud’s conjecture. Heredity
(Edinb) 1995;74:481–90.
25. Lynch M, Walsh B, et al. Genetics and Analysis of Quantita-
tive Traits. Sunderland, MA: Sinauer; 1998.
26. Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of
genetic correlations across human diseases and traits. Nat
Genet. Nature Publishing Group; 2015;47:1236–41.
27. Zhu Z, Zhang F, Hu H, et al. Integration of summary data
from GWAS and eQTL studies predicts complex trait gene
targets. Nat Genet 2016;48:481–7.
28. Pickrell JK, Berisa T, Liu JZ, et al. Detection and interpretation
of shared genetic influences on 42 human traits. Nat Genet
2016, 78;709–717.
29. Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test
for colocalisation between pairs of genetic association stud-
ies using summary statistics. PLoS Genet 2014;10:e1004383.
30. Aschard H, Guillemot V, Vilhjalmsson B, et al. Covariate se-
lection for association screening in multiphenotype genetic
studies. Nat Genet 2017;49:1789–95.
31. WichmannH-E, Gieger C, Illig T. KORA-gen–resource for pop-
ulation genetics, controls and a broad spectrum of disease
phenotypes. Gesundheitswesen 2005;67(Suppl 1):S26–30.
32. Illig T, Gieger C, Zhai G, et al. A genome-wide perspec-
tive of genetic variation in human metabolism. Nat Genet
2010;42:137–41.
33. Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28 141
individuals identifies common variants within five new
loci that influence uric acid concentrations. PLoS Genet
2009;5:e1000504.
34. Kim S. ppcor: an R package for a fast calculation to semi-
partial correlation coefficients. Commun Stat Appl Methods
2015;22:665–74.
35. Marchetti GM. Independencies induced from a graphical
Markov model after marginalization and conditioning: the
R Package ggm. J Stat Softw 2006;15, 1–15. http://www.jstats
oft.org/v15/i06/.
36. Fabregat-Traver D, Sharapov SZ, Hayward C, et al. High-
performance mixedmodels based genome-wide association
analysis with omicABEL software. F1000Research 2014;3:200.
37. Beasley TM, Erickson S, Allison DB. Rank-based inverse nor-
mal transformations are increasingly used, but are theymer-
ited? Behav Genet 2009;39:580–95.
38. Devlin B, Roeder K. Genomic control for association studies.
Biometrics 1999;55:997–1004.
39. Tsepilov Y, Sharapov S, Aulchenko Y. A network-based
conditional genetic association analysis of the human
metabolome [Source Code], CodeOcean, 2018; https://doi.or
g/10.24433/CO.3b5ea77b-859a-4db9-af44-b8b6aeb88664.v2.
40. Pers TH, Karjalainen JM, Chan Y, et al. Biological interpre-
tation of genome-wide association studies using predicted
gene functions. Nat Commun 2015;6:5890.
41. Staley JR, Blackshaw J, Kamat MA, et al. PhenoScanner:
a database of human genotype–phenotype associations.
Bioinformatics 2016;32:3207–9.
42. Tsepilov YA, Sharapov SZ, Zaytseva OO, et al. Supporting
data for “A network-based conditional genetic association
analysis of the human metabolome.” GigaScience Database
2018. http://dx.doi.org/10.5524/100507.
D
ow
nloaded from
 https://academ
ic.oup.com
/gigascience/article-abstract/7/12/giy137/5214749 by guest on 21 N
ovem
ber 2019
